Paper Review Records
全部论文审稿周期
20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
41
天
First-Line Immune Checkpoint Inhibitors in Older Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis
作者
Dalila Incognito; Andrea D’Arienzo; Sergio Facchini; Chiara Barraco; Antonio Picone; Antonella Nicastro; Giuliana Ciappina; Giordana Di Mauro; Antonio Ieni; Massimiliano Berretta; Gaetano Facchini展开收起
作者单位
1. Medical Oncology Unit, Department of Human Pathology “G. Barresi”, School of Specialization in Medical Oncology, University of Messina, 98122 Messina, Italy; 2. Translational Molecular Medicine and Surgery, Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 3. Oncology Unit, “Santa Maria Delle Grazie” Hospital, 80078 Pozzuoli, Italy; 4. Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Naples, Italy; 5. Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy; 6. Section of Experimental Medicine, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy; 7. Applied Biology and Experimental Medicine, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166 Messina, Italy; 8. Department of Human Pathology of Adult and Childhood “Gaetano Barresi”, University of Messina, 98121 Messina, Italy; 9. Division of Medical Oncology, “G. Martino” University Hospital, University of Messina, 98124 Messina, Italy展开收起
44
天
SBRT for Colorectal Cancer Liver Metastasis Is a Safe and Effective Treatment Option—A Single Institution Retrospective Analysis
作者
Nitsan Peled Oved; Marc Wygoda; Adi Levy; Mor Oved; Philip Blumenfeld; Ayala Hubert; Aron Popovtzer; Tamar Peretz; Aviad Zick; Tal Falick Michaeli展开收起
作者单位
1. Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel; 2. Department of Military Medicine and “Tzamert”, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel; 3. Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel展开收起
83
天
Functionally Informed Hand Knob Reveals Structural Connectome Differences in Motor-Eloquent Tumours
作者
Sankhya Prakashvel; Filippo Sinosi; Laura Ferrari; Feras Fayez; Sabina Patel; Yasir A. Chowdhury; Andrea Perera; Nida Kalyal; Mariam Awan; Alba Diaz-Baamonde; Ana Mirallave-Pescador; Keyoumars Ashkan; Ranjeev Bhangoo; Francesco Vergani; Jose Pedro Lavrador展开收起
作者单位
1. Queens’ Hospital Romford, London RM7 0AG, UK; 2. King’s College Hospital, London SE5 9RS, UK; 3. University College London Hospital, London NW1 2BU, UK展开收起
18
天
Plasma 4β-Hydroxycholesterol Predicts Ribociclib CYP3A-Mediated Metabolism, but Not Plasma Exposure, in Patients with Primary Brain Cancer
作者
Charuka Wickramasinghe; Xun Bao; Yuanyuan Jiang; Jun Jiang; Yang Yue; Nader Sanai; Jing Li展开收起
作者单位
1. Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R Street, HWCRC, Room 523, Detroit, MI 48201, USA; 2. Barrow Neurological Institute, St. Joseph’s Hospital & Medical Center, Phoenix, AZ 85004, USA展开收起
27
天
Post-Recurrence Outcomes Associated with a Bevacizumab-Containing First-Recurrence Strategy in Glioblastoma: A Propensity-Weighted Single-Center Cohort Study with Competing-Risk Analysis
作者
Enes Yeşilbaş; Sema Sezgin Göksu展开收起
作者单位
1. Department of Medical Oncology, Ankara Etlik City Hospital, Ankara 06010, Türkiye; 2. Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya 07070, Türkiye展开收起
32
天
Incorporating Metastatic Disease Burden into Prognostic Assessment in Metastatic Castration-Resistant Prostate Cancer: The MIRA Score
作者
Mario Uccello; Panagiotis J. Vlachostergios; Aruni Ghose; Stergios Boussios展开收起
作者单位
1. Royal United Hospitals Bath NHS Foundation Trust, Bath BA1 3NG, UK; 2. Department of Medical Oncology, IASO Thessalias Hospital, 41500 Larissa, Greece; 3. Department of Medical Oncology, Ioannina University Hospital, 45500 Ioannina, Greece; 4. Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece; 5. Division of Hematology & Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA; 6. Cancer Division, University College London Hospitals NHS Foundation Trust, London NW1 2BU, UK; 7. Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK; 8. School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King’s College London, London SE1 1UL, UK; 9. Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT1 1QU, UK; 10. AELIA Organisation, 9Th Km Thessaloniki-Thermi, 57001 Thessaloniki, Greece展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天